↓ Skip to main content

Clozapine-Associated Myocarditis

Overview of attention for article published in Drug Safety, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
wikipedia
11 Wikipedia pages

Citations

dimensions_citation
172 Dimensions

Readers on

mendeley
85 Mendeley
Title
Clozapine-Associated Myocarditis
Published in
Drug Safety, January 2013
DOI 10.2165/00002018-200730010-00005
Pubmed ID
Authors

Steven J. Haas, Richard Hill, Henry Krum, Danny Liew, Andrew Tonkin, Lisa Demos, Karen Stephan, John McNeil

Abstract

Clozapine is an antipsychotic medication associated with a lower suicide rate compared with other antipsychotic agents. Clozapine is used specifically in patients for whom previous therapy was inadequate or not tolerated, and is the only antipsychotic agent associated with the development of myocarditis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Netherlands 1 1%
Canada 1 1%
Australia 1 1%
Spain 1 1%
Romania 1 1%
Unknown 78 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 20%
Other 15 18%
Student > Bachelor 7 8%
Student > Ph. D. Student 6 7%
Professor > Associate Professor 6 7%
Other 19 22%
Unknown 15 18%
Readers by discipline Count As %
Medicine and Dentistry 48 56%
Psychology 4 5%
Nursing and Health Professions 3 4%
Neuroscience 3 4%
Agricultural and Biological Sciences 2 2%
Other 8 9%
Unknown 17 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2022.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Drug Safety
#594
of 1,852 outputs
Outputs of similar age
#54,086
of 290,307 outputs
Outputs of similar age from Drug Safety
#65
of 235 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,307 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.